Excellent Tolerability within depression

Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk

Rampono et al.:. Br J Clin Pharmacol (2006) 62:3; 316-322

Escitalopram in the Long-term Treatment of Major Depressive Disorder.

Wade et al., Ann Clin Psychiatry. 2006 Apr-Jun;18(2):83-9

Discontinuation symptoms in depression and anxiety disorders

David S. Baldwin, Stuart A. Montgomery, Rico Nil and Malcolm Lader, Int J Neuropsychopharmacology 2005; 9: 1-12

A Double-blind Comparison of Escitalopram and Paroxetine in the Treatment of Generalized Anxiety Disorder

Bielski et al., Annals of Clinical Psychiatry 2005 17:65-69

Prevention of relapse in older patients with major depressive disorder by Escitalopram treatment

Gorwood P, Weiller E, Lemming O and Katona C, Hôpital Louis Mourier, Colombes, France; H. Lundbeck A/S, Copenhagen, Denmark; Kent Institute of Medicine & Health Sciences, University of Kent, UK

Escitalopram continuation treatment prevents relapse of depressive episodes

Rapaport et al., Journal of Clinical Psychiatry 2004;65:44-49

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

Montgomery et al., Neuropsychobiology 2004;50:57-64

A Double-Blind Comparison of Escitalopram and Venlafaxine Extended Release in the Treatment of Major Depressive Disorder

Bielski et al., Journal of Clinical Psychiatry 2004; 65: 1190-1196

Last updated: 23.05.2006

Key publications

Key publications within depression

Superior Efficacy

Excellent Tolerability

Fast Onset of Action

Key publications within anxiety

Unique Serotonin Dual-Action

Key publications within Obsessive Compulsive Disorder (OCD)

Literature Search

PubMed
Google Scholar